Flow cytometry analysis of splenic lymphocytes revealed an increased number of CD4+ and CD8+ T cells in the treatment group compared to the control, indicating that the recombinant virus could induce tumor cell death through the activation of cellular immunity [73]. This evidence concerns the gene CD8A and neoplasm.